Health Care Funds Push For Class Cert. In Celexa Drug MDL
Health care fund providers seeking to recover money lost because of Forest Laboratories' allegedly fraudulent promotion of its drugs in treating pediatric depression pressed a Massachusetts federal judge to certify their...To view the full article, register now.
Already a subscriber? Click here to view full article